BMP4 signaling induces senescence and modulates the oncogenic phenotype of A549 lung adenocarcinoma cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 286, Issue 1 30-1, 2004, Pages

  Buckley, S ^a   Shi, W ^a   Driscoll, B ^a   Ferrario, A ^a   Anderson, K ^a   Warburton, D ^a  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Bone morphogenetic protein 4; Engelbreth Holm Swarm matrix invasion; Senescence associated galactosidase activity; Telomerase; Xenograft tumor

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; PROTEIN BCL 2; SMAD1 PROTEIN; TELOMERASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SENESCENCE; SIGNAL TRANSDUCTION; TELOMERE; WILD TYPE; XENOGRAFT;

EID: 0346096906     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00160.2003     Document Type: Article

References (25)

1. Chen W, Fu X, and Sheng Z. Review of current progress in the structure and function of Smad proteins. Chin Med J (Engl) 115: 446-450, 2002.
2. Croce MV, Colussi AG, Price MR, and Segal-Eiras A. Identification and characterization of different subpopulations in human lung adenocarcinoma cell line (A549). Pathol Oncol Res 5: 197-204, 1999.
3. Driscoll B, Buckley S, Bui KC, Anderson K, and Warburton D. Telomerase in alveolar epithelial development and repair. Am J Physiol Lung Cell Mol Physiol 279: L1191-L1198, 2000.
4. Franzen A and Heldin NE. BMP-7-induced cell cycle arrest of anaplastic thyroid carcinoma cells via p21 (CIP1) and p27 (KIP1). Biochem Biophys Res Commun 285: 773-781, 2001.
5. Fujii M, Takeda K, Imamura T, Aoki H, Sampath TK, Enomoto S, Kawahata M, Kato M, Ichijo H, and Miyazono K. Roles of bone morphogenetic protein type 1 receptors and SMAD proteins in osteoblast and chondroblast differentiation. Mol Biol Cell 10: 3801-3813, 1999.
6. Ghosh-Choudbury N, Woodruff K, Qi W, Celeste A, Abboud SL, and Ghosh-Choudbury G. Bone morphogenetic protein-2 blocks MDA MB231 human breast cancer cell proliferation by inhibiting cyclin-dependent kinase-mediated retinoblastome protein phosphorylation. Biochem Biophys Res Commun 272: 705-711, 2000.
7. Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A, and Sundan A. Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 97: 516-522, 2001.
8. Itoh S, Itoh F, Gourmans MG, and Ten Dijke P. Signaling of transforming growth factor-beta family members through Smad proteins. Eur J Biochem 267: 6954-6967, 2000.
9. Jiang Y, Liang H, Guo W, Kottickal LV, and Nagarajan L. Differential expression of a novel C-terminally truncated splice form of SMAD5 in hematopoietic stem cells and leukemia. Blood 95: 3945-3950, 2000.
10. Jonson T, Albrechtsson E, Axelson J, Heidenblad M, Gorunova L, Johansson B, and Hoglund M. Altered expression of TGF-β receptors and mitogenic effects of TGF-β in pancreatic carcinomas. Int J Oncol 19: 71-81, 2001.
11. Katakura Y, Nakata E, Miura T, and Shirahata S. Transforming growth factor β triggers two independent-senescent programs in cancer cells. Biochem Biophys Res Commun 255: 110-115, 1999.
12. Katakura Y, Yamamoto K, Miyake O, Yasuda T, Uehara N, Nakata E, Kawamoto S, and Shirahata S. Bidirectional regulation of telomerase activity in a subline derived from human lung adenocarcinoma. Biochem Biophys Res Commun 237: 313-317, 1997.
13. Lieber A, Smith B, Szakal A, Nelson-Rees W, and Todaro G. A continuous tumor cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17: 62-70, 1976.
14. Massague J, Blain SW, and Lo RS. TGF beta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309, 2000.
15. Nohe A, Hassel S, Ehrich M, Neubauer F, Sebald W, Henis YI, and Kraus P. The role of bone morphogenic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways. J Biol Chem 277: 5330-5338, 2002.
16. Pouliot F and Labrie C. Role of SMAD1 and SMAD4 proteins in the induction of p21WAF1, Cip1 during bone morphogenic protein-induced growth arrest in human breast cancer cells. J Endocrinol 172: 187-198, 2002.
17. Tada A, Kato H, Takenaga K, and Hagesawa S. Transforming growth factor beta 1 increases the expressions of high molecular weight tropomyosin isoforms and vinculin and suppresses the transformed phenotype in lung carcinoma calls. Cancer Lett 121: 31-37, 1997.
18. Tada A, Nishihara T, and Kato H. Bone morphogenetic protein 2 suppresses the transformed phenotype and restores actin microfilaments of human lung cancer A549 cells. Oncol Rep 5: 1137-1140, 1998.
19. Takagi Y, Koumura H, Futamura M, Aoki S, Yamaguchi K, Kida H, Tanemura H, Shimokara K, and Saji S. Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 78: 1152-1155, 1998.
20. Von Bubnoff A and Cho KW. Intracellular BMP signaling in vertebrates: pathway or network? Dev Biol 239: 1-14, 2001.
21. Wach S, Schirmacher P, Protschka M, and Blessing M. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses tumor formation by induction of apoptosis and down-regulation of fos/jun family members. Oncogene 20: 7761-7769, 2001.
22. Wingo PA, Ries LA, Parker SL, and Heath CW Jr. Long term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev 7: 271-282, 1998.
23. Xu HJ, Zhou Y, Wan J, Perng GS, Kruzelock R, Kong CT, Bast RC, Mills GB, Li J, and Hu SX. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene 15: 2589-2596, 1997.
24. Yanagisawa K, Uchida K, Nagatake M, Masuda A, Sugiyama M, Saito T, Yamaki K, Takahashi T, and Osada H. Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Oncogene 19: 2305-2311, 2000.
25. Zucker S, Lysik RM, Malik M, Bauer BA, Caamano J, and Klein-Szanto AJ. Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revertant cell lines: not an invariant correlation with metastasis. Int J Cancer 52: 366-371, 1992.